Citation Impact
Citing Papers
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer
1996
Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor
1994
Clinical utility of telomerase in cancer
2002
Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer
2003
Resection for Esophageal Cancer: Strategies for Optimal Management
2008
Ribosome-inactivating proteins from plants
1993
Present Status of Boron Neutron Capture Therapy
1992
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Cell toxicity of superparamagnetic iron oxide nanoparticles
2009
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Isolation and characterization of kirsten murine sarcoma virus‐transformed mouse keratinocytes resistant to transforming growth factor beta
1990
Review: Hydrogels for cell immobilization
2000
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
Esophageal Cancer
2003 Standout
Cyclin D and oncogenesis
1993
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Cyclins and oncogenesis
1993
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Overexpression of hypoxia-inducible-factor 1α(HIF-1α) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage
2003
Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World
2001
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Curative Resection for Esophageal Adenocarcinoma
2001
Detection and chemoradiotherapeutic evaluation of advanced esophageal squamous cell carcinoma using gallium-67 SPET: a preliminary study
2002
Oesophageal carcinoma
2013 Standout
Therapies Directed Against Epidermal Growth Factor Receptor in Aerodigestive Carcinomas
2007
Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.
1993
Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging
2001
Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis
1993
Recent advances in iron oxide nanocrystal technology for medical imaging☆
2006
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
1994 Standout
The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival
1993
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate
2006
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
1993 StandoutNature
Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
1996
Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy
1994
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake
2002
Head and Neck Cancer
2001 Standout
Mammalian G1 cyclins
1993 Standout
Prospects of Colloidal Nanocrystals for Electronic and Optoelectronic Applications
2009 Standout
p53 Mutations in Human Cancers
1991 StandoutScience
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Protein kinase inhibitors for the treatment of cancer
1996
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Cancer Cell Cycles
1996 StandoutScience
Hydrogels for Tissue Engineering
2001 Standout
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
1998
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Molecular Staging of Lymph Nodes from Patients with Esophageal Adenocarcinoma
2005
Inorganic nanoparticles in porous coordination polymers
2016 StandoutNobel
Surgical Management of Esophageal Carcinoma
1999
Esophageal Cancer: Associated Factors with Special Reference to the Kashmir Valley
2012
Cadherin Cell Adhesion Receptors as a Morphogenetic Regulator
1991 StandoutScience
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
The retinoblastoma protein and cell cycle control
1995 Standout
Prussian blue modified iron oxide magnetic nanoparticles and their high peroxidase-like activity
2010
In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies
2003
Antibody-Targeted Chemotherapy with the Calicheamicin Conjugate hu3S193- N -Acetyl γ Calicheamicin Dimethyl Hydrazide Targets Lewisy and Eliminates Lewisy-Positive Human Carcinoma Cells and Xenografts
2004
Adjuvant Chemotherapy for Resected Adenocarcinoma of the Esophagus, Gastro-Esophageal Junction, and Cardia: Phase II Trial (E8296) of the Eastern Cooperative Oncology Group
2004
Frequent mutation of the p53 gene in human esophageal cancer.
1990
Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas.
1989
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The Chemistry of Neutron Capture Therapy
1998 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Amplification and expression of the human cyclin D gene in esophageal cancer.
1992
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
1999 Standout
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Noninvasive Remote-Controlled Release of Drug Molecules in Vitro Using Magnetic Actuation of Mechanized Nanoparticles
2010 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Global cancer statistics, 2012
2015 Standout
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
2009
Nanooncology: The future of cancer diagnosis and therapy
2013
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Antibiofouling Polymer-Coated Superparamagnetic Iron Oxide Nanoparticles as Potential Magnetic Resonance Contrast Agents for in Vivo Cancer Imaging
2006
Development and in Vitro Studies of Epidermal Growth Factor−Dextran Conjugates for Boron Neutron Capture Therapy
1996
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
1993
A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.
1991 Standout
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
ß-Arrestin 2 Mediates Endocytosis of Type III TGF-ß Receptor and Down-Regulation of Its Signaling
2003 StandoutScienceNobel
Magnetic Nanoparticles and Their Applications in Medicine
2006
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
2004 StandoutScience
Works of Nobutoshi Ando being referenced
Improvement in the Results of Surgical Treatment of Advanced Squamous Esophageal Carcinoma During 15 Consecutive Years
2000
Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti-epidermal growth factor receptor antibody
1998
A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan clinical oncology group study
1997
Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas
1989
Meanings of c-erbB and int-2 Amplification in Superficial Esophageal Squamous Cell Carcinomas
1996
Stimulation by EGF of the growth of EGF receptor‐hyperproducing tumor cells in athymic mice
1987
Epidermal Growth Factor Receptors in Cancer Tissues of Esophagus, Lung, Pancreas, Colorectum, Breast and Stomach
1988
Surgery Plus Chemotherapy Compared With Surgery Alone for Localized Squamous Cell Carcinoma of the Thoracic Esophagus: A Japan Clinical Oncology Group Study—JCOG9204
2003
Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.
1991
Pharmacokinetics ofcis-diamminedichloroplatinum (II) given as low-dose and high-dose infusions
1996
High incidence of egf receptor hyperproduction in esophageal squamous‐cell carcinomas
1987
Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus
2000
Epidermal growth factor receptor-dependent cytotoxic effect of anti-EGFR antibody-ribonuclease conjugate on human cancer cells.
2000
67Ga Scanning in the Evaluation of Esophageal Carcinoma
1979
A Hybrid Artificial Esophagus Using Cultured Human Esophageal Epithelial Cells
1993
Ga-67 scan in patients with intrathoracic esophageal:Carcinoma planned for surgery
1982
Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the egf receptor
1989